Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Homo sapiens

ABSTRACT: Molecular alterations associated with breast cancer progression in the isogenic MCF10 model

PROVIDER: PRJNA308098 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR3089763.fastq.gz	Fastqsanger.gz
	SRR3089813.fastq.gz	Fastqsanger.gz
	SRR3089765.fastq.gz	Fastqsanger.gz
	SRR3089815.fastq.gz	Fastqsanger.gz
	SRR3089766.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 63

Similar Datasets

Effect of METTL3 knockdown on MCF10 breast cancer progression model

Project description:Effect of METTL3 knockdown on MCF10 breast cancer progression model

| PRJNA993659 | ENA

Genome reorganization and its functional impact during breast cancer progression

Project description:We used Micro-C to explore conformational changes in the cancer genome, using the MCF10 cell line as a model for breast cancer progression. We have generated 5kb-resolution maps in normal (MCF10A), pre-malignant (MCF10AT1), and metastatic (MCF10CA1a) breast cancer cell lines, and aim to identify differential enhancer-promoter interactions between the different stages of cancer progression that may contribute to oncogenesis.

2025-06-16 | GSE254045 | GEO

Effect of METTL3 knockdown on MCF10 breast cancer progression model

Project description:To investigate the cellular role of METTL3 in breast cancer progression, we established MCF10-A, MCF10-AT1, and MCF10-CA1H cell lines that had knockdown of METTL3 using CRISPR. We then performed gene expression profiling analysis using data obtained from RNA-seq of the various cell lines.

2023-11-20 | GSE237066 | GEO

Homo sapiens

Project description:Chromatin structure and CTCF across the MCF10 breast cancer progression series (HiC)

| PRJNA385494 | ENA

Homo sapiens

Project description:Chromatin structure and CTCF across the MCF10 breast cancer progression series (ChIP-Seq)

| PRJNA385492 | ENA

Runx1 stabilizes the mammary epithelial cell phenotype and prevents epithelial to mesenchymal transition

Project description:The Runx1 transcription factor is essential for hematopoietic differentiation and mutations underlie various leukemias. Here we demonstrate a role for Runx1 in the MCF10 cell series model of breast cancer progression. The highest level of Runx1 that occurs in normal like mammary epithelial cells (MCF10A) is decreased in tumorigenic (MCF10AT1) and metastatic (MCF10CA1a) breast cancer cells. We show that depletion of Runx1 in MCF10A cells results in striking changes in cell morphology and induction of epithelial-mesenchymal transition (EMT) via several signaling pathways. Analyses of breast tumors and patient survival data reveal that loss of Runx1 is associated with poor prognosis and decreased survival. Re-expressing Runx1 in MCF10AT1 breast cancer cells restores the epithelial phenotype. These results identify a novel function for Runx1 in sustaining normal epithelial morphology and preventing EMT. These mechanisms suggest Runx1 levels in early stage tumors can be used as a prognostic indicator of tumor progression.

2017-04-17 | GSE85857 | GEO

Hi-C profiling of cancer spheroids identifies 3D-growth-specific chromatin interactions in breast cancer endocrine resistance [RNA-Seq]

Project description:Organoids or spheroids have emerged as a physiologically relevant in vitro preclinical model to study patient-specific diseases. A recent study used spheroids of MCF10 cells to model breast cancer progression and identified targetable alterations more similar to those in vivo. Thus, it is practical and essential to explore and characterize the spheroids of the commonly used human breast cancer (BC) cells. This study conducted Hi-C analyses in three-dimensional (3D) spheroids of MCF10A, MCF7 and MCF7TR cells and compared TADs and looping genes with those in 2D monolayers. We found that chromatin domains and looping genes’ strength have drastically changed during the 3D culture growth, although we identified very similar numbers of TADs and looping genes. We further identified novel 3D growth-specific looping genes within Hippo relevant pathways, of which two genes showed potential prognostic values in measuring the outcome of the endocrine treatment. We finally confirmed a few selected Hippo relevant pathways genes with enhanced looping in breast cancer patient tissues’ organoid. Hence, our work has provided significant insights into our understanding of 3D-growth-specific chromatin architecture in tamoxifen-resistant breast cancer.

2021-09-29 | GSE165571 | GEO

Hi-C profiling of cancer spheroids identifies 3D-growth-specific chromatin interactions in breast cancer endocrine resistance [Hi-C]

2021-09-29 | GSE165570 | GEO

Proteomic breast cancer data set for exploring somatic mutations

Project description:MCF7, SKBR3 (breast cancer) and MCF10 (non-tumorigenic) cell extracts were explored by LC-MS/MS for the identification of protein-level mutations.

2019-07-25 | PXD014458 | Pride

Homo sapiens

Project description:Molecular Signature of Pregnancy Associated Breast Cancer (PABC)

| PRJNA144751 | ENA